Karen A. Dawes will retire from Repligen’s board effective September 30, 2026, after more than two decades of service. The timing follows completion of a successful CEO transition, while Dawes said Repligen has an outstanding Leadership team and board supporting its next phase of growth.
Key Highlights
- Karen A. Dawes notified Repligen of her retirement decision on September 10, 2026.
- Dawes has served on Repligen’s board for more than twenty years.
- Repligen said the retirement is unrelated to any disagreement over operations, policies or procedures.
REPLIGEN CORP (NASDAQ: RGEN) will see director Karen A. Dawes retire from its board effective September 30, 2026, after more than two decades of service. Dawes linked the timing to the completion of a successful CEO transition.
Board Notice and Company Position
Dawes notified Repligen of her decision on September 10, 2026. She described her board service as a privilege and said she was proud of what had been accomplished during her tenure. Dawes expressed confidence in Repligen’s leadership team and board as the company moves into its next phase of growth. The retirement is not connected to any disagreement with Repligen over its operations, policies or procedures.
FAQs
Q: When will Karen Dawes retire from Repligen’s board?
A: Karen A. Dawes will retire from Repligen’s board on September 30, 2026. She notified the company of her decision on September 10, 2026.
Q: Why is Karen Dawes retiring from Repligen’s board?
A: Dawes said the successful CEO transition was complete and that the timing was right for her retirement. She expressed confidence in Repligen’s leadership team and board.
Q: Who is Repligen’s president and chief executive officer?
A: The article does not identify Repligen’s president and chief executive officer by name. It only refers to the completion of a successful CEO transition and the company’s leadership team.
Download Free Report – Explore 3 Stock Ideas & Industry Insights
Unlock 3 stock ideas and key industry insights in our free report. This information is general in nature and does not consider your personal objectives, financial situation, or needs. It is not financial advice.
All investments involve risk—consider independent advice before making any investment decisions.
View 3 Research Reports
Disclaimer:
Kalkine Equities LLC, with Delaware File Number 4697384, Foreign Qualification Registration in California File Number 202109211078, and Texas File Number 805521396, is authorized to provide general advice only. The information on https://kalkine.com/ does not take into account any of your investment objectives, financial situation or needs. You should consider the appropriateness of advice taking into account your own objectives, financial situation and needs and seek independent financial advice before making any financial decisions. The link to our Terms and Conditions and Privacy Policy has been provided for your reference. On the date of publishing the reports (mentioned on the website), employees and/or associates of Kalkine do not hold positions in any of the stocks covered on the website. These stocks can change any time and readers of the reports should not consider these stocks as advice or recommendations later.